| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 1.16e-10 | 884 | 55 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | transporter activity | GJA1 GJA3 GJB1 GJB2 SLC29A3 ABCA2 ATP8B4 CLCN5 KCNB1 NALCN GJB6 CFTR SLC5A9 ANO5 CATSPER3 CACNA1G ATP11A APOB | 4.91e-09 | 1289 | 55 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | gap junction channel activity | 6.70e-09 | 25 | 55 | 5 | GO:0005243 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 TNFRSF10C SSTR2 SSTR4 | 1.05e-08 | 1353 | 55 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | channel activity | GJA1 GJA3 GJB1 GJB2 CLCN5 KCNB1 NALCN GJB6 CFTR ANO5 CATSPER3 CACNA1G | 1.51e-08 | 525 | 55 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GJA1 GJA3 GJB1 GJB2 CLCN5 KCNB1 NALCN GJB6 CFTR ANO5 CATSPER3 CACNA1G | 1.54e-08 | 526 | 55 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | wide pore channel activity | 5.36e-08 | 37 | 55 | 5 | GO:0022829 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GJA1 GJA3 GJB1 GJB2 SLC29A3 ABCA2 CLCN5 KCNB1 NALCN GJB6 CFTR SLC5A9 ANO5 CATSPER3 CACNA1G | 4.35e-07 | 1180 | 55 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | gap junction channel activity involved in cell communication by electrical coupling | 1.64e-06 | 9 | 55 | 3 | GO:1903763 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.73e-06 | 133 | 55 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.33e-06 | 140 | 55 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 7.45e-06 | 2 | 55 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.17e-05 | 51 | 55 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 3.37e-05 | 23 | 55 | 3 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 3.84e-05 | 24 | 55 | 3 | GO:0019957 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 4.92e-05 | 26 | 55 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 4.92e-05 | 26 | 55 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 6.17e-05 | 28 | 55 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | somatostatin receptor activity | 7.41e-05 | 5 | 55 | 2 | GO:0004994 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.02e-04 | 33 | 55 | 3 | GO:0019956 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.44e-04 | 37 | 55 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | vasopressin receptor activity | 1.55e-04 | 7 | 55 | 2 | GO:0005000 | |
| GeneOntologyMolecularFunction | gap junction hemi-channel activity | 1.55e-04 | 7 | 55 | 2 | GO:0055077 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.02e-04 | 196 | 55 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | peptide binding | 2.34e-04 | 318 | 55 | 6 | GO:0042277 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.53e-04 | 459 | 55 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.89e-04 | 793 | 55 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.04e-04 | 334 | 55 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 4.20e-04 | 53 | 55 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | floppase activity | 8.72e-04 | 16 | 55 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.04e-03 | 758 | 55 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.58e-03 | 182 | 55 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.65e-03 | 184 | 55 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 1.66e-03 | 22 | 55 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 1.66e-03 | 22 | 55 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.72e-03 | 86 | 55 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.32e-03 | 26 | 55 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 2.43e-03 | 97 | 55 | 3 | GO:0004896 | |
| GeneOntologyMolecularFunction | hormone binding | 2.88e-03 | 103 | 55 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.88e-03 | 103 | 55 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 4.74e-03 | 123 | 55 | 3 | GO:0030165 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.96e-03 | 125 | 55 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 7.13e-03 | 46 | 55 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 8.06e-03 | 49 | 55 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 8.06e-03 | 49 | 55 | 2 | GO:0048487 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.34e-03 | 151 | 55 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 8.38e-03 | 50 | 55 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 8.50e-03 | 152 | 55 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.97e-03 | 465 | 55 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | sodium channel activity | 9.04e-03 | 52 | 55 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | cytokine binding | 9.28e-03 | 157 | 55 | 3 | GO:0019955 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 9.94e-03 | 477 | 55 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.06e-02 | 165 | 55 | 3 | GO:0140375 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.17e-02 | 171 | 55 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.17e-02 | 171 | 55 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.22e-02 | 174 | 55 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 1.28e-02 | 177 | 55 | 3 | GO:0141108 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 6.83e-08 | 1395 | 55 | 17 | GO:0007186 |
| GeneOntologyBiologicalProcess | gap junction assembly | 1.70e-07 | 19 | 55 | 4 | GO:0016264 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GJA1 CXCR3 CLCN5 KCNB1 NALCN GPER1 SMDT1 STIMATE CFTR SLC5A9 NMUR1 CCR1 ANO5 CATSPER3 CACNA1G GP5 | 3.43e-07 | 1374 | 55 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | gap junction-mediated intercellular transport | 6.23e-07 | 7 | 55 | 3 | GO:1990349 | |
| GeneOntologyBiologicalProcess | calcium ion transport | GJA1 CXCR3 NALCN GPER1 SMDT1 STIMATE CCR1 CATSPER3 CACNA1G GP5 | 8.28e-07 | 509 | 55 | 10 | GO:0006816 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GJA1 CXCR3 CLCN5 KCNB1 NALCN GPER1 SMDT1 STIMATE CFTR SLC5A9 ANO5 CATSPER3 CACNA1G GP5 | 9.09e-07 | 1115 | 55 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 1.06e-06 | 202 | 55 | 7 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 1.06e-06 | 202 | 55 | 7 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 1.10e-06 | 203 | 55 | 7 | GO:0035150 | |
| GeneOntologyBiologicalProcess | metal ion transport | GJA1 CXCR3 KCNB1 NALCN GPER1 SMDT1 STIMATE CFTR SLC5A9 CCR1 CATSPER3 CACNA1G GP5 | 1.64e-06 | 1000 | 55 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CXCR3 CLCN5 KCNB1 NALCN GPER1 SMDT1 STIMATE CFTR SLC5A9 ANO5 CATSPER3 CACNA1G GP5 | 1.98e-06 | 1017 | 55 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 2.05e-06 | 435 | 55 | 9 | GO:0051047 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 2.11e-06 | 224 | 55 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | intercellular transport | 2.92e-06 | 11 | 55 | 3 | GO:0010496 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 3.12e-06 | 38 | 55 | 4 | GO:0015874 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 3.39e-06 | 344 | 55 | 8 | GO:0003018 | |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle contraction | 3.88e-06 | 12 | 55 | 3 | GO:0070472 | |
| GeneOntologyBiologicalProcess | female pregnancy | 4.25e-06 | 249 | 55 | 7 | GO:0007565 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle contraction | 5.03e-06 | 13 | 55 | 3 | GO:0070471 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of Sertoli cell barrier | 6.98e-06 | 2 | 55 | 2 | GO:1904446 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | GJA1 CXCR3 KCNB1 NALCN GPER1 SMDT1 STIMATE CFTR SLC5A9 CCR1 CATSPER3 CACNA1G GP5 | 8.13e-06 | 1157 | 55 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 8.84e-06 | 392 | 55 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.05e-05 | 286 | 55 | 7 | GO:0007188 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 1.10e-05 | 404 | 55 | 8 | GO:1903532 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 1.15e-05 | 290 | 55 | 7 | GO:0044703 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 1.26e-05 | 294 | 55 | 7 | GO:0044706 | |
| GeneOntologyBiologicalProcess | positive regulation of vasoconstriction | 1.30e-05 | 54 | 55 | 4 | GO:0045907 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 1.76e-05 | 121 | 55 | 5 | GO:0042310 | |
| GeneOntologyBiologicalProcess | endocrine process | 1.90e-05 | 123 | 55 | 5 | GO:0050886 | |
| GeneOntologyBiologicalProcess | regulation of establishment of Sertoli cell barrier | 2.09e-05 | 3 | 55 | 2 | GO:1904444 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | GJA1 HCAR3 HCAR2 CXCR3 OXTR KCNB1 GPER1 STIMATE CFTR CCR1 CACNA1G SSTR4 | 2.18e-05 | 1081 | 55 | 12 | GO:0051050 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CXCR3 KCNB1 NALCN GPER1 SMDT1 STIMATE CFTR SLC5A9 CATSPER3 CACNA1G GP5 | 2.64e-05 | 922 | 55 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 2.78e-05 | 133 | 55 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CXCR3 KCNB1 NALCN GPER1 SMDT1 STIMATE CFTR SLC5A9 CATSPER3 CACNA1G GP5 | 3.21e-05 | 942 | 55 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | positive regulation of adiponectin secretion | 4.17e-05 | 4 | 55 | 2 | GO:0070165 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 4.20e-05 | 145 | 55 | 5 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 4.42e-05 | 801 | 55 | 10 | GO:0051046 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 4.44e-05 | 358 | 55 | 7 | GO:0015850 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 4.47e-05 | 26 | 55 | 3 | GO:0014061 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 5.61e-05 | 28 | 55 | 3 | GO:0048243 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 6.46e-05 | 81 | 55 | 4 | GO:0071384 | |
| GeneOntologyBiologicalProcess | epididymis development | 6.95e-05 | 5 | 55 | 2 | GO:1905867 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by vasopressin | 6.95e-05 | 5 | 55 | 2 | GO:0001992 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 8.22e-05 | 167 | 55 | 5 | GO:0007043 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid catabolic process | 1.01e-04 | 34 | 55 | 3 | GO:0050995 | |
| GeneOntologyBiologicalProcess | positive regulation of norepinephrine secretion | 1.04e-04 | 6 | 55 | 2 | GO:0010701 | |
| GeneOntologyBiologicalProcess | somatostatin receptor signaling pathway | 1.04e-04 | 6 | 55 | 2 | GO:0038169 | |
| GeneOntologyBiologicalProcess | somatostatin signaling pathway | 1.04e-04 | 6 | 55 | 2 | GO:0038170 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.11e-04 | 35 | 55 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | 1.12e-04 | 415 | 55 | 7 | GO:0019216 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 1.25e-04 | 96 | 55 | 4 | GO:0051937 | |
| GeneOntologyBiologicalProcess | circulatory system process | 1.26e-04 | 733 | 55 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 1.36e-04 | 98 | 55 | 4 | GO:0019229 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 1.36e-04 | 740 | 55 | 9 | GO:1903530 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 1.65e-04 | 40 | 55 | 3 | GO:0003161 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 1.66e-04 | 194 | 55 | 5 | GO:0050714 | |
| GeneOntologyBiologicalProcess | adiponectin secretion | 1.93e-04 | 8 | 55 | 2 | GO:0070162 | |
| GeneOntologyBiologicalProcess | regulation of adiponectin secretion | 1.93e-04 | 8 | 55 | 2 | GO:0070163 | |
| GeneOntologyBiologicalProcess | establishment of Sertoli cell barrier | 1.93e-04 | 8 | 55 | 2 | GO:0097368 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 2.14e-04 | 323 | 55 | 6 | GO:0051924 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone secretion | 2.15e-04 | 205 | 55 | 5 | GO:0046887 | |
| GeneOntologyBiologicalProcess | response to progesterone | 2.35e-04 | 45 | 55 | 3 | GO:0032570 | |
| GeneOntologyBiologicalProcess | positive regulation of uterine smooth muscle contraction | 2.48e-04 | 9 | 55 | 2 | GO:0070474 | |
| GeneOntologyBiologicalProcess | monoamine transport | 2.60e-04 | 116 | 55 | 4 | GO:0015844 | |
| GeneOntologyBiologicalProcess | blood circulation | 3.01e-04 | 648 | 55 | 8 | GO:0008015 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 3.10e-04 | 10 | 55 | 2 | GO:0060371 | |
| GeneOntologyBiologicalProcess | signal release | 3.16e-04 | 653 | 55 | 8 | GO:0023061 | |
| GeneOntologyBiologicalProcess | secretion | GJA1 HCAR3 HCAR2 ADRA2C OXTR KCNB1 GPER1 CFTR CCR1 CACNA1G SSTR4 | 3.22e-04 | 1221 | 55 | 11 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 3.29e-04 | 350 | 55 | 6 | GO:0050708 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 3.35e-04 | 124 | 55 | 4 | GO:0007218 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 3.55e-04 | 355 | 55 | 6 | GO:0046883 | |
| GeneOntologyBiologicalProcess | chloride transport | 3.78e-04 | 128 | 55 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | response to estradiol | 3.78e-04 | 128 | 55 | 4 | GO:0032355 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 3.90e-04 | 1249 | 55 | 11 | GO:0048878 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 4.35e-04 | 866 | 55 | 9 | GO:0055082 | |
| GeneOntologyBiologicalProcess | secretion by cell | 4.49e-04 | 1064 | 55 | 10 | GO:0032940 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 4.96e-04 | 246 | 55 | 5 | GO:0045216 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 5.16e-04 | 381 | 55 | 6 | GO:0048545 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 5.25e-04 | 59 | 55 | 3 | GO:0045777 | |
| GeneOntologyBiologicalProcess | sinoatrial node development | 5.34e-04 | 13 | 55 | 2 | GO:0003163 | |
| GeneOntologyBiologicalProcess | lipid translocation | 5.51e-04 | 60 | 55 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 5.79e-04 | 61 | 55 | 3 | GO:0003254 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5.79e-04 | 61 | 55 | 3 | GO:0007187 | |
| GeneOntologyBiologicalProcess | organic cation transport | 6.05e-04 | 145 | 55 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | membrane organization | 6.43e-04 | 914 | 55 | 9 | GO:0061024 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.66e-04 | 400 | 55 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 6.92e-04 | 403 | 55 | 6 | GO:1904951 | |
| GeneOntologyBiologicalProcess | cholesterol biosynthetic process | 6.97e-04 | 65 | 55 | 3 | GO:0006695 | |
| GeneOntologyBiologicalProcess | regulation of alcohol biosynthetic process | 6.97e-04 | 65 | 55 | 3 | GO:1902930 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 6.97e-04 | 65 | 55 | 3 | GO:0097035 | |
| GeneOntologyBiologicalProcess | vesicle docking | 6.97e-04 | 65 | 55 | 3 | GO:0048278 | |
| GeneOntologyBiologicalProcess | secondary alcohol biosynthetic process | 6.97e-04 | 65 | 55 | 3 | GO:1902653 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 7.06e-04 | 266 | 55 | 5 | GO:0043270 | |
| GeneOntologyBiologicalProcess | alcohol biosynthetic process | 7.58e-04 | 154 | 55 | 4 | GO:0046165 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 7.58e-04 | 154 | 55 | 4 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 7.62e-04 | 67 | 55 | 3 | GO:0050433 | |
| GeneOntologyBiologicalProcess | cellular response to glucocorticoid stimulus | 7.95e-04 | 68 | 55 | 3 | GO:0071385 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 8.19e-04 | 577 | 55 | 7 | GO:0043269 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.20e-04 | 275 | 55 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | export from cell | 8.39e-04 | 1153 | 55 | 10 | GO:0140352 | |
| GeneOntologyCellularComponent | connexin complex | 2.42e-09 | 22 | 54 | 5 | GO:0005922 | |
| GeneOntologyCellularComponent | gap junction | 3.89e-08 | 37 | 54 | 5 | GO:0005921 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GJA1 SLC29A3 ABCA2 ATP8B4 SPPL2A STX5 CLCN5 ATR DSG1 GPER1 AVPR2 LNPEP CFTR RNF13 ATP11A APOB | 1.09e-07 | 1307 | 54 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | GJA1 SLC29A3 ABCA2 ATP8B4 SPPL2A STX5 CLCN5 ATR DSG1 GPER1 AVPR2 LNPEP CFTR RNF13 ATP11A APOB | 1.32e-07 | 1325 | 54 | 16 | GO:0012506 |
| GeneOntologyCellularComponent | endosome | GJA1 SLC29A3 ABCA2 ADRA2C SPPL2A CLCN5 GPER1 AVPR2 LNPEP CFTR RNF13 CCR3 ATP11A APOB | 1.05e-06 | 1167 | 54 | 14 | GO:0005768 |
| GeneOntologyCellularComponent | lateral plasma membrane | 3.54e-06 | 90 | 54 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | membrane protein complex | GJA1 GJA3 GJB1 GJB2 ABCA2 STX5 KCNB1 NALCN SMDT1 GJB6 CFTR CATSPER3 CACNA1G TNFRSF10C GP5 | 3.78e-06 | 1498 | 54 | 15 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane protein complex | GJA1 GJA3 GJB1 GJB2 ABCA2 KCNB1 GJB6 CATSPER3 CACNA1G TNFRSF10C GP5 | 4.27e-06 | 785 | 54 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | transporter complex | 1.05e-05 | 550 | 54 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | GJA1 GJB1 SPPL2A STX5 GPER1 DPY19L1 STIMATE CFTR RDH10 RNF13 ANO5 ATP11A APOB | 1.87e-05 | 1293 | 54 | 13 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | GJA1 GJB1 SPPL2A STX5 GPER1 DPY19L1 STIMATE CFTR RDH10 RNF13 ANO5 ATP11A APOB | 1.96e-05 | 1299 | 54 | 13 | GO:0098827 |
| GeneOntologyCellularComponent | lysosomal membrane | 2.29e-05 | 462 | 54 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.29e-05 | 462 | 54 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | GJA1 GJB1 SPPL2A STX5 GPER1 DPY19L1 STIMATE CFTR RDH10 RNF13 ANO5 ATP11A APOB | 2.46e-05 | 1327 | 54 | 13 | GO:0042175 |
| GeneOntologyCellularComponent | lysosome | SLC29A3 ABCA2 SPPL2A CLCN5 LNPEP CFTR RNF13 WDR45B ATP11A APOB | 3.71e-05 | 811 | 54 | 10 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | SLC29A3 ABCA2 SPPL2A CLCN5 LNPEP CFTR RNF13 WDR45B ATP11A APOB | 3.71e-05 | 811 | 54 | 10 | GO:0000323 |
| GeneOntologyCellularComponent | vacuolar membrane | 4.42e-05 | 507 | 54 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | vacuole | SLC29A3 ABCA2 SPPL2A CLCN5 LNPEP CFTR RNF13 WDR45B ATP11A APOB | 1.00e-04 | 913 | 54 | 10 | GO:0005773 |
| GeneOntologyCellularComponent | early endosome | 2.27e-04 | 481 | 54 | 7 | GO:0005769 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.77e-04 | 523 | 54 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.17e-04 | 378 | 54 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 5.27e-04 | 61 | 54 | 3 | GO:0030660 | |
| GeneOntologyCellularComponent | cell body | 5.71e-04 | 929 | 54 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 5.84e-04 | 14 | 54 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | cell-cell junction | 7.80e-04 | 591 | 54 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | apical part of cell | 7.87e-04 | 592 | 54 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | endosome membrane | 8.68e-04 | 602 | 54 | 7 | GO:0010008 | |
| GeneOntologyCellularComponent | calcium channel complex | 8.92e-04 | 73 | 54 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.12e-03 | 79 | 54 | 3 | GO:0030669 | |
| GeneOntologyCellularComponent | neuronal cell body | 1.28e-03 | 835 | 54 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.55e-03 | 487 | 54 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | cell surface | 2.01e-03 | 1111 | 54 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 2.27e-03 | 101 | 54 | 3 | GO:0045334 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.30e-03 | 215 | 54 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | cation channel complex | 3.17e-03 | 235 | 54 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 3.20e-03 | 114 | 54 | 3 | GO:0005798 | |
| GeneOntologyCellularComponent | endosome lumen | 5.53e-03 | 43 | 54 | 2 | GO:0031904 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 6.30e-03 | 46 | 54 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 6.50e-03 | 147 | 54 | 3 | GO:0030665 | |
| GeneOntologyCellularComponent | tertiary granule | 8.78e-03 | 164 | 54 | 3 | GO:0070820 | |
| GeneOntologyCellularComponent | dendrite membrane | 9.23e-03 | 56 | 54 | 2 | GO:0032590 | |
| HumanPheno | Psoriasiform dermatitis | 3.24e-07 | 33 | 24 | 5 | HP:0003765 | |
| HumanPheno | Abnormality of nail color | 1.40e-06 | 19 | 24 | 4 | HP:0100643 | |
| HumanPheno | Limb joint contracture | 2.38e-05 | 469 | 24 | 10 | HP:0003121 | |
| HumanPheno | Abnormal tendon morphology | GJA1 GJB1 GJB2 SLC29A3 STX5 ATR NALCN GJB6 RNF13 WDR45B ANO5 ATP11A APOB | 4.02e-05 | 875 | 24 | 13 | HP:0100261 |
| HumanPheno | Lower-limb joint contracture | 4.96e-05 | 403 | 24 | 9 | HP:0005750 | |
| HumanPheno | Yellow nails | 6.36e-05 | 3 | 24 | 2 | HP:0011367 | |
| HumanPheno | Lip fissure | 6.36e-05 | 3 | 24 | 2 | HP:0031250 | |
| HumanPheno | Elbow flexion contracture | 7.20e-05 | 97 | 24 | 5 | HP:0002987 | |
| HumanPheno | Epidermal acanthosis | 1.02e-04 | 54 | 24 | 4 | HP:0025092 | |
| HumanPheno | Onycholysis | 1.16e-04 | 21 | 24 | 3 | HP:0001806 | |
| HumanPheno | Elbow contracture | 1.26e-04 | 109 | 24 | 5 | HP:0034391 | |
| HumanPheno | Generalized hypotrichosis | 1.27e-04 | 4 | 24 | 2 | HP:0004528 | |
| HumanPheno | Cobblestone-like hyperkeratosis | 1.27e-04 | 4 | 24 | 2 | HP:0031288 | |
| HumanPheno | Joint contracture | GJA1 GJB1 GJB2 SLC29A3 STX5 ATR NALCN GJB6 RNF13 WDR45B ANO5 ATP11A | 1.52e-04 | 843 | 24 | 12 | HP:0034392 |
| HumanPheno | Palmoplantar keratoderma | 1.56e-04 | 114 | 24 | 5 | HP:0000982 | |
| HumanPheno | Abnormal nail attachment | 1.74e-04 | 24 | 24 | 3 | HP:0025756 | |
| HumanPheno | Dilatated internal auditory canal | 2.11e-04 | 5 | 24 | 2 | HP:0004458 | |
| HumanPheno | Hair follicle neoplasm | 2.11e-04 | 5 | 24 | 2 | HP:0012843 | |
| HumanPheno | Trichilemmoma | 2.11e-04 | 5 | 24 | 2 | HP:0012844 | |
| HumanPheno | Palmoplantar hyperkeratosis | 2.78e-04 | 129 | 24 | 5 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 2.99e-04 | 131 | 24 | 5 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 3.10e-04 | 132 | 24 | 5 | HP:0007556 | |
| HumanPheno | Punctate keratitis | 3.15e-04 | 6 | 24 | 2 | HP:0011859 | |
| HumanPheno | Hypotrichosis | 3.15e-04 | 6 | 24 | 2 | HP:0001006 | |
| HumanPheno | Delayed pubic bone ossification | 4.40e-04 | 7 | 24 | 2 | HP:0008788 | |
| HumanPheno | Posterior blepharitis | 4.40e-04 | 7 | 24 | 2 | HP:0025610 | |
| HumanPheno | Orthokeratotic hyperkeratosis | 4.40e-04 | 7 | 24 | 2 | HP:0025080 | |
| HumanPheno | Deafness | 5.45e-04 | 35 | 24 | 3 | HP:0000404 | |
| HumanPheno | Flexion contracture | GJA1 GJB1 GJB2 SLC29A3 STX5 ATR NALCN GJB6 RNF13 ANO5 ATP11A | 5.61e-04 | 817 | 24 | 11 | HP:0001371 |
| HumanPheno | Equinus calcaneus | 5.86e-04 | 8 | 24 | 2 | HP:0008138 | |
| HumanPheno | Stapes ankylosis | 5.86e-04 | 8 | 24 | 2 | HP:0000381 | |
| HumanPheno | Limbal stem cell deficiency | 5.86e-04 | 8 | 24 | 2 | HP:0032107 | |
| HumanPheno | Nail dystrophy | 6.70e-04 | 156 | 24 | 5 | HP:0008404 | |
| HumanPheno | Absent pubic hair | 7.51e-04 | 9 | 24 | 2 | HP:0002555 | |
| HumanPheno | Hyposthenuria | 7.51e-04 | 9 | 24 | 2 | HP:0003158 | |
| HumanPheno | Abnormal urine osmolality | 7.51e-04 | 9 | 24 | 2 | HP:0033358 | |
| HumanPheno | Folliculitis | 7.51e-04 | 9 | 24 | 2 | HP:0025084 | |
| HumanPheno | Clubbing of fingers | 7.52e-04 | 39 | 24 | 3 | HP:0100759 | |
| HumanPheno | Mixed hearing impairment | 8.10e-04 | 40 | 24 | 3 | HP:0000410 | |
| HumanPheno | Abnormal epidermal morphology | 8.71e-04 | 94 | 24 | 4 | HP:0011124 | |
| HumanPheno | Abnormal ossification of the pubic bone | 9.36e-04 | 10 | 24 | 2 | HP:0009105 | |
| HumanPheno | Hypernatremia | 9.36e-04 | 10 | 24 | 2 | HP:0003228 | |
| HumanPheno | Limited elbow movement | 9.39e-04 | 168 | 24 | 5 | HP:0002996 | |
| HumanPheno | Abnormality of the plantar skin of foot | 1.02e-03 | 171 | 24 | 5 | HP:0100872 | |
| HumanPheno | Upper-limb joint contracture | 1.04e-03 | 362 | 24 | 7 | HP:0100360 | |
| HumanPheno | Nail dysplasia | 1.12e-03 | 264 | 24 | 6 | HP:0002164 | |
| HumanPheno | Amniotic constriction ring | 1.14e-03 | 11 | 24 | 2 | HP:0009775 | |
| HumanPheno | Aplastic/hypoplastic lacrimal glands | 1.14e-03 | 11 | 24 | 2 | HP:0008038 | |
| HumanPheno | Alopecia of scalp | 1.15e-03 | 45 | 24 | 3 | HP:0002293 | |
| Domain | GPCR_Rhodpsn_7TM | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 4.22e-12 | 670 | 55 | 17 | IPR017452 |
| Domain | 7tm_1 | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 4.98e-12 | 677 | 55 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 6.00e-12 | 685 | 55 | 17 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 6.88e-12 | 691 | 55 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 OR2Y1 OR4C46 GPR141 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 7.04e-12 | 692 | 55 | 17 | IPR000276 |
| Domain | CONNEXINS_1 | 2.07e-09 | 19 | 55 | 5 | PS00407 | |
| Domain | Connexin_N | 2.76e-09 | 20 | 55 | 5 | IPR013092 | |
| Domain | CONNEXINS_2 | 2.76e-09 | 20 | 55 | 5 | PS00408 | |
| Domain | Connexin | 2.76e-09 | 20 | 55 | 5 | PF00029 | |
| Domain | Connexin_CCC | 2.76e-09 | 20 | 55 | 5 | SM01089 | |
| Domain | Connexin_CS | 2.76e-09 | 20 | 55 | 5 | IPR017990 | |
| Domain | Connexin | 2.76e-09 | 20 | 55 | 5 | IPR000500 | |
| Domain | Connexin_CCC | 2.76e-09 | 20 | 55 | 5 | IPR019570 | |
| Domain | CNX | 2.76e-09 | 20 | 55 | 5 | SM00037 | |
| Domain | HCAR2/3_rcpt | 8.51e-06 | 2 | 55 | 2 | IPR028017 | |
| Domain | Chemokine_rcpt | 1.32e-05 | 16 | 55 | 3 | IPR000355 | |
| Domain | 7TM_GPCR_Srsx | 1.94e-05 | 112 | 55 | 5 | SM01381 | |
| Domain | Somatstn_rcpt | 8.47e-05 | 5 | 55 | 2 | IPR000586 | |
| Domain | Vasoprsn_rcpt | 8.47e-05 | 5 | 55 | 2 | IPR001817 | |
| Domain | Ion_trans_dom | 3.53e-04 | 114 | 55 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.53e-04 | 114 | 55 | 4 | PF00520 | |
| Domain | Channel_four-helix_dom | 6.32e-04 | 57 | 55 | 3 | IPR027359 | |
| Domain | - | 6.32e-04 | 57 | 55 | 3 | 1.20.120.350 | |
| Domain | P_typ_ATPase_c | 7.57e-04 | 14 | 55 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 7.57e-04 | 14 | 55 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 7.57e-04 | 14 | 55 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 7.57e-04 | 14 | 55 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 7.57e-04 | 14 | 55 | 2 | PF16209 | |
| Domain | PA | 1.41e-03 | 19 | 55 | 2 | PF02225 | |
| Domain | PA_domain | 1.41e-03 | 19 | 55 | 2 | IPR003137 | |
| Domain | - | 3.99e-03 | 32 | 55 | 2 | 2.70.150.10 | |
| Domain | - | 3.99e-03 | 32 | 55 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 4.76e-03 | 35 | 55 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.03e-03 | 36 | 55 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 5.03e-03 | 36 | 55 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.03e-03 | 36 | 55 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.31e-03 | 37 | 55 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 5.31e-03 | 37 | 55 | 2 | PF00122 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 8.97e-13 | 186 | 48 | 12 | MM15994 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 2.65e-12 | 330 | 48 | 14 | M18334 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | HCAR3 CXCR3 ADRA2C OXTR GPER1 AVPR2 HCAR1 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 4.65e-11 | 260 | 48 | 12 | M39397 |
| Pathway | WP_GPCRS_NONODORANT | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 6.06e-11 | 266 | 48 | 12 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 2.43e-10 | 463 | 48 | 14 | M507 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | HCAR3 HCAR2 CXCR3 ADRA2C GPER1 MCHR2 HCAR1 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 4.11e-10 | 314 | 48 | 12 | M600 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 HCAR1 NMUR1 CCR3 SSTR2 SSTR4 | 8.05e-10 | 333 | 48 | 12 | MM14963 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 9.32e-10 | 197 | 48 | 10 | M12289 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | HCAR3 HCAR2 CXCR3 ADRA2C GPER1 HCAR1 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 2.56e-09 | 289 | 48 | 11 | MM15057 |
| Pathway | WP_GPCRS_PEPTIDE | 3.43e-09 | 70 | 48 | 7 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 5.61e-09 | 75 | 48 | 7 | M39696 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 HCAR1 NMUR1 CCR3 SSTR2 SSTR4 | 1.43e-08 | 430 | 48 | 12 | MM15160 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 MCHR2 HCAR1 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 5.05e-08 | 702 | 48 | 14 | M746 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 6.94e-08 | 32 | 48 | 5 | MM14730 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HCAR3 HCAR2 CXCR3 ADRA2C OXTR GPER1 AVPR2 HCAR1 NMUR1 CCR1 CCR3 SSTR2 SSTR4 | 1.53e-07 | 646 | 48 | 13 | MM14962 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.70e-07 | 38 | 48 | 5 | M14981 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 2.95e-07 | 197 | 48 | 8 | MM14970 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 3.63e-07 | 44 | 48 | 5 | MM14606 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 7.72e-07 | 51 | 48 | 5 | M26972 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC29A3 ABCA2 ATP8B4 CLCN5 NALCN SMDT1 AVPR2 CFTR SLC5A9 ANO5 ATP11A APOB | 2.06e-06 | 681 | 48 | 12 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC29A3 ABCA2 ATP8B4 CLCN5 NALCN SMDT1 AVPR2 CFTR SLC5A9 ANO5 ATP11A APOB | 4.60e-06 | 736 | 48 | 12 | M27287 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 9.93e-06 | 147 | 48 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.16e-05 | 151 | 48 | 6 | M39329 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.45e-05 | 272 | 48 | 7 | M13380 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 4.15e-05 | 630 | 48 | 10 | M11480 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 9.12e-05 | 26 | 48 | 3 | M4047 | |
| Pathway | WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION | 1.27e-04 | 29 | 48 | 3 | M39797 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 1.34e-04 | 725 | 48 | 10 | M27507 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.69e-04 | 6 | 48 | 2 | M27289 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.69e-04 | 6 | 48 | 2 | MM14989 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 1.71e-04 | 32 | 48 | 3 | MM1492 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 2.81e-04 | 645 | 48 | 9 | MM15232 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.18e-04 | 176 | 48 | 5 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.80e-04 | 183 | 48 | 5 | M997 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 9.53e-04 | 57 | 48 | 3 | M625 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.49e-03 | 17 | 48 | 2 | MM14731 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 2.29e-03 | 21 | 48 | 2 | M27067 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 3.01e-03 | 85 | 48 | 3 | M48315 | |
| Pathway | REACTOME_FERTILIZATION | 3.50e-03 | 26 | 48 | 2 | M26922 | |
| Pathway | WP_GPCRS_OTHER | 3.88e-03 | 93 | 48 | 3 | M39629 | |
| Pubmed | 1.03e-12 | 9 | 55 | 5 | 14595769 | ||
| Pubmed | Distribution of genes for gap junction membrane channel proteins on human and mouse chromosomes. | 5.60e-12 | 4 | 55 | 4 | 1849321 | |
| Pubmed | Connexin family members target to lipid raft domains and interact with caveolin-1. | 2.79e-11 | 5 | 55 | 4 | 11980479 | |
| Pubmed | 6.92e-11 | 18 | 55 | 5 | 15081111 | ||
| Pubmed | The novel mouse connexin39 gene is expressed in developing striated muscle fibers. | 6.92e-11 | 18 | 55 | 5 | 15466892 | |
| Pubmed | Role of connexin (gap junction) genes in cell growth control and carcinogenesis. | 8.37e-11 | 6 | 55 | 4 | 10196667 | |
| Pubmed | An update on connexin genes and their nomenclature in mouse and man. | 9.38e-11 | 19 | 55 | 5 | 14681012 | |
| Pubmed | Genetic diseases and gene knockouts reveal diverse connexin functions. | 1.95e-10 | 7 | 55 | 4 | 10099690 | |
| Pubmed | 3.90e-10 | 8 | 55 | 4 | 9861669 | ||
| Pubmed | 3.90e-10 | 8 | 55 | 4 | 1332196 | ||
| Pubmed | 7.01e-10 | 9 | 55 | 4 | 19864490 | ||
| Pubmed | 7.01e-10 | 9 | 55 | 4 | 20089884 | ||
| Pubmed | 1.00e-09 | 200 | 55 | 8 | 18240029 | ||
| Pubmed | Expression of connexins in embryonic mouse neocortical development. | 1.17e-09 | 10 | 55 | 4 | 17640036 | |
| Pubmed | 1.83e-09 | 11 | 55 | 4 | 8631157 | ||
| Pubmed | 1.83e-09 | 11 | 55 | 4 | 15255617 | ||
| Pubmed | Dysregulation of Connexin Expression Plays a Pivotal Role in Psoriasis. | 3.74e-09 | 3 | 55 | 3 | 34199748 | |
| Pubmed | Altered permeability and modulatory character of connexin channels during mammary gland development. | 3.74e-09 | 3 | 55 | 3 | 15265710 | |
| Pubmed | Connexin32 can restore hearing in connexin26 deficient mice. | 3.74e-09 | 3 | 55 | 3 | 21813206 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 21454438 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 10209481 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 26046157 | ||
| Pubmed | Connexin expression and gap junction communication compartments in the developing mouse limb. | 3.74e-09 | 3 | 55 | 3 | 1338686 | |
| Pubmed | Connexin43, but not connexin30, contributes to adult neurogenesis in the dentate gyrus. | 3.74e-09 | 3 | 55 | 3 | 28689039 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 15334670 | ||
| Pubmed | Effects of high fat diet on GPR109A and GPR81 gene expression. | 3.74e-09 | 3 | 55 | 3 | 22842580 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 15140236 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 22098503 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 23637189 | ||
| Pubmed | Connexins 30 and 43 expression changes in relation to age-related hearing loss. | 3.74e-09 | 3 | 55 | 3 | 38359484 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 34852802 | ||
| Pubmed | The Roles of Connexin 26, 32, and 43 as Prognostic Factors for Gastric Cancer. | 3.74e-09 | 3 | 55 | 3 | 32727784 | |
| Pubmed | Connexin dynamics in the privileged wound healing of the buccal mucosa. | 3.74e-09 | 3 | 55 | 3 | 23627777 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 33589833 | ||
| Pubmed | An Escherichia coli-Based Assay to Assess the Function of Recombinant Human Hemichannels. | 3.74e-09 | 3 | 55 | 3 | 27789753 | |
| Pubmed | Developmental regulation of gap junction gene expression during mouse embryonic development. | 3.74e-09 | 3 | 55 | 3 | 2060697 | |
| Pubmed | Analysis of multiple gap junction gene products in the rodent and human mammary gland. | 3.74e-09 | 3 | 55 | 3 | 7664837 | |
| Pubmed | Expression of connexins 26, 32 and 43 in the human colon--an immunohistochemical study. | 3.74e-09 | 3 | 55 | 3 | 15704645 | |
| Pubmed | Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines. | 3.74e-09 | 3 | 55 | 3 | 34830068 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 18267319 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 1319348 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 15013803 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 1425357 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 19633298 | ||
| Pubmed | 2.66e-08 | 20 | 55 | 4 | 1370487 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 19047060 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 1964417 | ||
| Pubmed | 5.03e-08 | 126 | 55 | 6 | 17897319 | ||
| Pubmed | Expression of connexins in the developing olfactory system of the mouse. | 7.46e-08 | 6 | 55 | 3 | 1332989 | |
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 19017998 | ||
| Pubmed | Autophagy modulates dynamics of connexins at the plasma membrane in a ubiquitin-dependent manner. | 7.46e-08 | 6 | 55 | 3 | 22496425 | |
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 19502010 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 20593197 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 23261389 | ||
| Pubmed | Peripheral lymphangiogenesis in mice depends on ectodermal connexin-26 (Gjb2). | 1.30e-07 | 7 | 55 | 3 | 21807945 | |
| Pubmed | Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice. | 1.30e-07 | 7 | 55 | 3 | 9508777 | |
| Pubmed | 1.30e-07 | 7 | 55 | 3 | 8834803 | ||
| Pubmed | Splice variant IVS2-2A>G in the SLC26A5 (Prestin) gene in five Estonian families with hearing loss. | 2.08e-07 | 8 | 55 | 3 | 19027966 | |
| Pubmed | Genetic analysis of presbycusis by arrayed primer extension. | 2.08e-07 | 8 | 55 | 3 | 18988928 | |
| Pubmed | 2.08e-07 | 8 | 55 | 3 | 20668687 | ||
| Pubmed | 4.02e-07 | 179 | 55 | 6 | 18577758 | ||
| Pubmed | 4.46e-07 | 10 | 55 | 3 | 19523148 | ||
| Pubmed | 4.46e-07 | 10 | 55 | 3 | 10079507 | ||
| Pubmed | Assembly of the cochlear gap junction macromolecular complex requires connexin 26. | 4.46e-07 | 10 | 55 | 3 | 24590285 | |
| Pubmed | 4.46e-07 | 10 | 55 | 3 | 24705551 | ||
| Pubmed | 4.46e-07 | 10 | 55 | 3 | 22513384 | ||
| Pubmed | 8.15e-07 | 12 | 55 | 3 | 11501764 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 16103213 | ||
| Pubmed | Connexin Expression Is Altered in Liver Development of Yotari (dab1 -/-) Mice. | 1.68e-06 | 15 | 55 | 3 | 34639052 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 19549869 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 23700267 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 35809272 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 12484567 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 28186140 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25625422 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8033821 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20236118 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 23054685 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 30154797 | ||
| Pubmed | Connexin levels regulate keratinocyte differentiation in the epidermis. | 2.46e-06 | 2 | 55 | 2 | 17693411 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20022641 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 19887791 | ||
| Pubmed | Connexin 32 and 43 mutations: do they play a role in chronic rhinosinusitis? | 2.46e-06 | 2 | 55 | 2 | 24119489 | |
| Pubmed | The role of HCA2 (GPR109A) in regulating macrophage function. | 2.46e-06 | 2 | 55 | 2 | 23882124 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 36891315 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20442751 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 21538560 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 17368814 | ||
| Pubmed | Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. | 2.46e-06 | 2 | 55 | 2 | 38007572 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 26265468 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25288386 | ||
| Pubmed | GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. | 2.46e-06 | 2 | 55 | 2 | 12172392 | |
| Pubmed | Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. | 2.46e-06 | 2 | 55 | 2 | 24691444 | |
| Pubmed | Conformational maturation and post-ER multisubunit assembly of gap junction proteins. | 2.46e-06 | 2 | 55 | 2 | 19297523 | |
| Pubmed | Prevalence of DFNB1 mutations in Slovak patients with non-syndromic hearing loss. | 2.46e-06 | 2 | 55 | 2 | 22281373 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24774219 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31347703 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20381175 | ||
| Pubmed | Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis. | 2.46e-06 | 2 | 55 | 2 | 30659164 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31200317 | ||
| Interaction | GJB2 interactions | 1.88e-08 | 68 | 51 | 6 | int:GJB2 | |
| Interaction | CNST interactions | 5.22e-07 | 26 | 51 | 4 | int:CNST | |
| Interaction | CCL15 interactions | 1.27e-06 | 9 | 51 | 3 | int:CCL15 | |
| Interaction | GJA3 interactions | 2.27e-05 | 22 | 51 | 3 | int:GJA3 | |
| Interaction | GJB3 interactions | 2.98e-05 | 24 | 51 | 3 | int:GJB3 | |
| Interaction | STX12 interactions | 4.14e-05 | 253 | 51 | 6 | int:STX12 | |
| Interaction | PIGH interactions | 5.34e-05 | 161 | 51 | 5 | int:PIGH | |
| Interaction | YIPF3 interactions | 1.06e-04 | 186 | 51 | 5 | int:YIPF3 | |
| Interaction | TLCD4 interactions | 1.24e-04 | 101 | 51 | 4 | int:TLCD4 | |
| Interaction | STIMATE interactions | 1.31e-04 | 7 | 51 | 2 | int:STIMATE | |
| Interaction | ATP2B4 interactions | 1.35e-04 | 196 | 51 | 5 | int:ATP2B4 | |
| Interaction | SLC41A1 interactions | 1.41e-04 | 40 | 51 | 3 | int:SLC41A1 | |
| Interaction | COX18 interactions | 1.74e-04 | 8 | 51 | 2 | int:COX18 | |
| Interaction | TMEM9B interactions | 1.78e-04 | 111 | 51 | 4 | int:TMEM9B | |
| Interaction | LGALS1 interactions | 1.84e-04 | 332 | 51 | 6 | int:LGALS1 | |
| Interaction | TCAF2 interactions | 1.88e-04 | 44 | 51 | 3 | int:TCAF2 | |
| Interaction | SST interactions | 2.23e-04 | 9 | 51 | 2 | int:SST | |
| Interaction | SLC22A9 interactions | 2.41e-04 | 120 | 51 | 4 | int:SLC22A9 | |
| Cytoband | 12q24.31 | 1.25e-04 | 80 | 55 | 3 | 12q24.31 | |
| Cytoband | 15q21.2 | 5.60e-04 | 29 | 55 | 2 | 15q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q12 | 2.82e-03 | 234 | 55 | 3 | chr13q12 | |
| GeneFamily | Gap junction proteins | 3.01e-09 | 22 | 49 | 5 | 314 | |
| GeneFamily | Hydroxy-carboxylic acid receptors | 1.87e-08 | 3 | 49 | 3 | 200 | |
| GeneFamily | Arginine vasopressin and oxytocin receptors | 4.30e-05 | 4 | 49 | 2 | 259 | |
| GeneFamily | Somatostatin receptors | 7.16e-05 | 5 | 49 | 2 | 257 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 3.19e-04 | 10 | 49 | 2 | 1091 | |
| GeneFamily | ATPase phospholipid transporting | 7.39e-04 | 15 | 49 | 2 | 1210 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.16e-03 | 394 | 49 | 5 | 471 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 185 | 55 | 5 | 6938ac3cab536cf8a474eba441ce6dcdfcc43b53 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 185 | 55 | 5 | 0e7351cd6d6e6e8c29573042e168da50ee496cfc | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.55e-06 | 188 | 55 | 5 | 068b761a7b6778bc6d6c776b5f09094aac87477e | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.55e-06 | 188 | 55 | 5 | c95134245dab9057eb1f9b54acb371470f9c8b86 | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.55e-06 | 188 | 55 | 5 | 3ee321a74f04eb0982c7b4977426946b0ae6e5a9 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-06 | 190 | 55 | 5 | cb62ece5929896dfba30a4f563c6ba5a5712b71e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-06 | 190 | 55 | 5 | fedd266198d294d8da8c9e217e5e0cb8b2e1b566 | |
| ToppCell | COVID-19_Severe-Myeloid_G|COVID-19_Severe / Disease group, lineage and cell class | 3.73e-06 | 190 | 55 | 5 | 8a81cb90273c361e9fdfaa0a31806da253fa1388 | |
| ToppCell | BL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.35e-06 | 196 | 55 | 5 | f64d7fed31e418c55fe946744d78c3cbecec9bbf | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 196 | 55 | 5 | 36c01e0feea33448222010c21442b9fac671bd7d | |
| ToppCell | NS-critical-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.45e-06 | 197 | 55 | 5 | f38037dfa6c33e9336130d0cc65eaba0f120efb9 | |
| ToppCell | critical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.57e-06 | 198 | 55 | 5 | 4da73dc3acb29d70b160903600d2bf7fdab34333 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-06 | 200 | 55 | 5 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.63e-05 | 139 | 55 | 4 | fa0eedebf53317928022c3bed391ce99a2114f98 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 148 | 55 | 4 | a261c6d3d9cf0311c053fca66c37d39e66db6ad8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like-IPs_and_early_cortical_neurons|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 148 | 55 | 4 | c0237ba7d4040b6a497094b362dfb8b3a97a7d06 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 151 | 55 | 4 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 160 | 55 | 4 | 08696d93ff42a1beca23c70ab3e0d082cfff4aa7 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.51e-05 | 168 | 55 | 4 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 168 | 55 | 4 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 168 | 55 | 4 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-05 | 169 | 55 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-05 | 169 | 55 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-05 | 169 | 55 | 4 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-05 | 169 | 55 | 4 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | severe_COVID-19-Neutrophil|World / disease group, cell group and cell class (v2) | 5.77e-05 | 170 | 55 | 4 | dfc807e0dd66179490a258ecbe8eb439e715799d | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.77e-05 | 170 | 55 | 4 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 5.77e-05 | 170 | 55 | 4 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 171 | 55 | 4 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.91e-05 | 171 | 55 | 4 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 171 | 55 | 4 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.91e-05 | 171 | 55 | 4 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-05 | 172 | 55 | 4 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 6.04e-05 | 172 | 55 | 4 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | severe_COVID-19-Neutrophil|severe_COVID-19 / disease group, cell group and cell class (v2) | 6.04e-05 | 172 | 55 | 4 | 8f4bcb9b2bbf8b4333f673d8ad6bb88dfda4792a | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 6.04e-05 | 172 | 55 | 4 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.18e-05 | 173 | 55 | 4 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.18e-05 | 173 | 55 | 4 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.18e-05 | 173 | 55 | 4 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.18e-05 | 173 | 55 | 4 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 173 | 55 | 4 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.18e-05 | 173 | 55 | 4 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.18e-05 | 173 | 55 | 4 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.60e-05 | 176 | 55 | 4 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 55 | 4 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 55 | 4 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 55 | 4 | 8f0873d348f37c823294b698043319b6608b678a | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-05 | 178 | 55 | 4 | b89c4d015b44bf538aa39969ef8778877c8023f1 | |
| ToppCell | Severe-Myeloid-Neutrophil|Severe / Condition, Lineage, Cell class and cell subclass | 6.90e-05 | 178 | 55 | 4 | 454313efe59d71e7327b9758efabf2d893e4a8fd | |
| ToppCell | Severe-Myeloid-Neutrophil-|Severe / Condition, Lineage, Cell class and cell subclass | 6.90e-05 | 178 | 55 | 4 | 8618ae891d62bf70fe860ff7bb2d31868961aa13 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-05 | 178 | 55 | 4 | 89f0537459a321ded956bf70ad56fefc0854f8b0 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-05 | 178 | 55 | 4 | fb8f8d95f6b08378fb42c4076ee040276faa296f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.05e-05 | 179 | 55 | 4 | ae9d90a4eac2cfa545a764df84914c5801544278 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 710526abedc8e0f9ba19ad69220df4c9468ada8f | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.36e-05 | 181 | 55 | 4 | f737f2b1f35747b81fdd8996e289bde5c290af61 | |
| ToppCell | 11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 7.36e-05 | 181 | 55 | 4 | 193ee02f547a218b2fc13e1174ea4cff4f8a3450 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.36e-05 | 181 | 55 | 4 | 3457c1d431db4282be5a6243119e48960748ede7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.52e-05 | 182 | 55 | 4 | f9c013075477e77a8373c73301a51e7e3f35369c | |
| ToppCell | droplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | 40539ade8c3cd12b61f1cd0d493828e58282796b | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 7.68e-05 | 183 | 55 | 4 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.85e-05 | 184 | 55 | 4 | 4c7d05f1a4556b13cedbaaf88d67ac32d09b109b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-05 | 184 | 55 | 4 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-05 | 184 | 55 | 4 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.85e-05 | 184 | 55 | 4 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-05 | 184 | 55 | 4 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 185 | 55 | 4 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 185 | 55 | 4 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.18e-05 | 186 | 55 | 4 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.18e-05 | 186 | 55 | 4 | c7214e762b3b48197fdd0b36a50a4de2550a888f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.52e-05 | 188 | 55 | 4 | e9cef856a96a97afac5ecafe2ee91eff0d731e01 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.70e-05 | 189 | 55 | 4 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.70e-05 | 189 | 55 | 4 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.88e-05 | 190 | 55 | 4 | 8e254fc77dd1d2d2a4ce0700af3c37829ca089bf | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 8.88e-05 | 190 | 55 | 4 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Neutrophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.88e-05 | 190 | 55 | 4 | 5da4a90f56f66567614d84b9b437f559006ea51c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.06e-05 | 191 | 55 | 4 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.06e-05 | 191 | 55 | 4 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.06e-05 | 191 | 55 | 4 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.25e-05 | 192 | 55 | 4 | 545c3990cbe3c04bfd95a0ab7499d2c4af509be1 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.25e-05 | 192 | 55 | 4 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Neutrophil|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.25e-05 | 192 | 55 | 4 | 3db74359c30172a51177e00eac1f48f483e15578 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.25e-05 | 192 | 55 | 4 | f51b3fd962263920a6cae783ca7af13f5eb7aaa3 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.25e-05 | 192 | 55 | 4 | 4cd8f572e067bf5fe22f62fa868d7d332f097a8c | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.25e-05 | 192 | 55 | 4 | 6244541688f85917018a057aa0b3e5972934dfbc | |
| ToppCell | moderate-Myeloid-Neutrophil|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.25e-05 | 192 | 55 | 4 | 8105408400dac5dcb0ce62b558433257559c9f09 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.43e-05 | 193 | 55 | 4 | b044fca95f519ff2ceb378afe40a95911931a29e | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 9.82e-05 | 195 | 55 | 4 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.00e-04 | 196 | 55 | 4 | 93ff94fc2b2ca8bd6a6492cbc0b402daf5d63ea2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 196 | 55 | 4 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 196 | 55 | 4 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | moderate-Myeloid|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.00e-04 | 196 | 55 | 4 | 76a4c615ea7594e99c1a938d6900a1b262cc09f5 | |
| ToppCell | NS-moderate-d_16-33-Myeloid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.00e-04 | 196 | 55 | 4 | dc8483625f1188771eb98bd94757b25163b2fc2f | |
| Computational | Genes in the cancer module 146. | 9.74e-06 | 102 | 31 | 5 | MODULE_146 | |
| Computational | Membranal receptors. | 8.02e-05 | 517 | 31 | 8 | MODULE_64 | |
| Computational | Genes in the cancer module 288. | 1.58e-04 | 37 | 31 | 3 | MODULE_288 | |
| Computational | Secreted signaling molecules. | 8.34e-04 | 149 | 31 | 4 | MODULE_92 | |
| Drug | heptanol | 7.36e-10 | 42 | 55 | 6 | CID000008129 | |
| Drug | N-ethyl-N-(4-hydroxybutyl)nitrosamine | 1.33e-07 | 5 | 55 | 3 | CID000041223 | |
| Drug | C-X-S | 1.63e-07 | 52 | 55 | 5 | CID000070815 | |
| Drug | Cascade Blue | 1.77e-07 | 21 | 55 | 4 | CID000014886 | |
| Drug | thulium | 2.80e-07 | 111 | 55 | 6 | CID000023961 | |
| Drug | AC1MHEDP | 3.67e-07 | 61 | 55 | 5 | CID003002894 | |
| Drug | DDAVP | 5.13e-07 | 123 | 55 | 6 | CID000027991 | |
| Drug | octanol | 5.46e-07 | 66 | 55 | 5 | CID000000957 | |
| Drug | 18b-glycyrrhetic acid | 1.72e-06 | 83 | 55 | 5 | CID000003230 | |
| Drug | 17alpha-estradiol | GJA1 HCAR3 HCAR2 GJB1 CXCR3 OXTR CLCN5 KCNB1 GPER1 CFTR CCR1 CCR3 APOB SSTR2 | 1.80e-06 | 1303 | 55 | 14 | CID000000450 |
| Drug | AMD3451 | 2.89e-06 | 12 | 55 | 3 | CID000503774 | |
| Drug | 17-isoprogesterone | GJA1 HCAR3 HCAR2 GJB1 GJB2 ABCA2 OXTR GPER1 LNPEP GJB6 CFTR CCR3 APOB | 3.14e-06 | 1170 | 55 | 13 | CID000004920 |
| Drug | Pertussis Toxin | 3.18e-06 | 94 | 55 | 5 | ctd:D037342 | |
| Drug | Cu-cyclam | 3.51e-06 | 43 | 55 | 4 | CID000467374 | |
| Drug | Utedrin | 4.76e-06 | 14 | 55 | 3 | CID000005771 | |
| Drug | hexachlorobenzene | 4.99e-06 | 103 | 55 | 5 | CID000008370 | |
| Drug | N-ethyl-N-(4-hydroxybutyl)nitrosamine | 5.73e-06 | 2 | 55 | 2 | ctd:C010723 | |
| Drug | Heptanol | 5.73e-06 | 2 | 55 | 2 | ctd:D019850 | |
| Drug | AC1N7HR9 | 5.96e-06 | 49 | 55 | 4 | CID000002561 | |
| Drug | elaidamide | 5.96e-06 | 49 | 55 | 4 | CID000001930 | |
| Drug | Lucifer yellow | 7.86e-06 | 113 | 55 | 5 | CID006335488 | |
| Drug | Cycam | 1.06e-05 | 18 | 55 | 3 | CID000122080 | |
| Drug | SR 49059 | 1.26e-05 | 19 | 55 | 3 | CID000060943 | |
| Drug | quindine | 1.45e-05 | 219 | 55 | 6 | CID000001065 | |
| Drug | HCC-1 variant | 1.72e-05 | 3 | 55 | 2 | CID000482146 | |
| Drug | Calcium | 2.28e-05 | 493 | 55 | 8 | ctd:D002118 | |
| Drug | ANB-NOS | 2.28e-05 | 23 | 55 | 3 | CID003080866 | |
| Drug | ABT-418 | 2.28e-05 | 23 | 55 | 3 | CID000119380 | |
| Drug | Neuropeptide Ff | 2.34e-05 | 69 | 55 | 4 | CID000123797 | |
| Drug | sarafotoxins s6 | 3.43e-05 | 4 | 55 | 2 | ctd:C057354 | |
| Drug | Ethanediurea | 3.43e-05 | 4 | 55 | 2 | CID000074614 | |
| Drug | Niacin | 3.43e-05 | 4 | 55 | 2 | DB00627 | |
| Drug | ethylnylestradiol | GJA1 GJA3 GJB1 CXCR3 GJB2 OXTR GPER1 GJB6 CFTR CCR1 CCR3 APOB | 3.49e-05 | 1251 | 55 | 12 | CID000003285 |
| Drug | 4-Ser-8-ile-oxytocin | 3.74e-05 | 27 | 55 | 3 | CID000123960 | |
| Drug | AC1L9GJY | 3.74e-05 | 27 | 55 | 3 | CID000444581 | |
| Drug | iodide | 4.01e-05 | 534 | 55 | 8 | CID000024841 | |
| Drug | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 4.96e-05 | 402 | 55 | 7 | ctd:C093973 | |
| Drug | nalidixic acid | 5.40e-05 | 277 | 55 | 6 | CID000004421 | |
| Drug | Tgot | 5.70e-05 | 5 | 55 | 2 | CID003082106 | |
| Drug | chrysarobin | 5.70e-05 | 5 | 55 | 2 | ctd:C013883 | |
| Drug | acifran | 5.70e-05 | 5 | 55 | 2 | ctd:C036804 | |
| Drug | LYCH | 5.72e-05 | 31 | 55 | 3 | CID000093368 | |
| Drug | AC1NST48 | 8.46e-05 | 594 | 55 | 8 | CID005315496 | |
| Drug | L-366,509 | 8.54e-05 | 6 | 55 | 2 | CID003083288 | |
| Drug | L-371,257 | 8.54e-05 | 6 | 55 | 2 | CID006918320 | |
| Drug | oxypressin | 8.54e-05 | 6 | 55 | 2 | CID000164712 | |
| Drug | acetyl-leucyl-glutamyl-histidyl-aspartal | 8.54e-05 | 6 | 55 | 2 | ctd:C420218 | |
| Drug | phorbol acetate myristate | GJA1 GJA3 GJB1 GJB2 SPPL2A STX5 OXTR GJB6 CCR1 CACNA1G APOB SSTR2 | 1.03e-04 | 1399 | 55 | 12 | CID000004792 |
| Drug | ivermectin | 1.05e-04 | 101 | 55 | 4 | CID006435110 | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.18e-04 | 199 | 55 | 5 | 4826_UP | |
| Drug | Lucifer yellow VS | 1.19e-04 | 7 | 55 | 2 | CID000435216 | |
| Drug | Bim23268 | 1.19e-04 | 7 | 55 | 2 | CID005311026 | |
| Drug | Piperidino acetanilide | 1.19e-04 | 7 | 55 | 2 | CID000078402 | |
| Drug | CID10998045 | 1.19e-04 | 7 | 55 | 2 | CID010998045 | |
| Drug | potassium | ATRN HCAR3 HCAR2 GJB2 CLCN5 KCNB1 CFTR CATSPER3 CACNA1G SSTR2 | 1.32e-04 | 1008 | 55 | 10 | CID000000813 |
| Drug | flufenamic acid | 1.36e-04 | 108 | 55 | 4 | CID000003371 | |
| Drug | oxotremorine | 1.36e-04 | 108 | 55 | 4 | CID000004630 | |
| Drug | 2',3-dimethyl-4-aminobiphenyl | 1.59e-04 | 8 | 55 | 2 | ctd:C001042 | |
| Drug | L 366948 | 1.59e-04 | 8 | 55 | 2 | CID000188397 | |
| Drug | Ee 581 | 1.59e-04 | 8 | 55 | 2 | CID003036100 | |
| Drug | BIM 23034 | 1.59e-04 | 8 | 55 | 2 | CID005492589 | |
| Drug | oleylamide | 1.59e-04 | 8 | 55 | 2 | ctd:C029407 | |
| Drug | Somatostatin | 1.59e-04 | 8 | 55 | 2 | ctd:D013004 | |
| Drug | Nicotinic Acids | 1.59e-04 | 8 | 55 | 2 | ctd:D009539 | |
| Drug | verapamil | 1.70e-04 | 490 | 55 | 7 | CID000002520 | |
| Drug | mono-(2-ethylhexyl)phthalate | 1.71e-04 | 658 | 55 | 8 | ctd:C016599 | |
| Drug | TAK-779 | 1.88e-04 | 46 | 55 | 3 | CID000183789 | |
| Drug | NSC3364 | 1.91e-04 | 118 | 55 | 4 | CID000025439 | |
| Drug | Lypressin | 2.01e-04 | 47 | 55 | 3 | CID000005772 | |
| Drug | AC1MIZWH | 2.04e-04 | 9 | 55 | 2 | CID003083001 | |
| Drug | Tyr(3)-sms | 2.04e-04 | 9 | 55 | 2 | CID000123864 | |
| Drug | acifran | 2.04e-04 | 9 | 55 | 2 | CID000051576 | |
| Drug | Hydrin 1 | 2.04e-04 | 9 | 55 | 2 | CID000195374 | |
| Drug | Ucb 35625 | 2.04e-04 | 9 | 55 | 2 | CID000458342 | |
| Drug | X Bb | 2.04e-04 | 9 | 55 | 2 | CID000445281 | |
| Drug | 2,3,2-tet | 2.04e-04 | 9 | 55 | 2 | CID000078479 | |
| Drug | AC1L9KQO | 2.27e-04 | 49 | 55 | 3 | CID000447335 | |
| Drug | Duratocin | 2.55e-04 | 10 | 55 | 2 | CID000071715 | |
| Drug | G4-D | 2.55e-04 | 10 | 55 | 2 | CID000444914 | |
| Drug | Deamino Arginine Vasopressin | 2.55e-04 | 10 | 55 | 2 | ctd:D003894 | |
| Drug | antineutrophil cytoplasmic antibody | 2.71e-04 | 52 | 55 | 3 | CID000002201 | |
| Drug | cladosporin | 2.71e-04 | 52 | 55 | 3 | ctd:C000488 | |
| Drug | ABAP | 2.87e-04 | 53 | 55 | 3 | CID000001969 | |
| Drug | glibenclamide | 3.11e-04 | 382 | 55 | 6 | CID000003488 | |
| Drug | Dpmetyravp | 3.11e-04 | 11 | 55 | 2 | CID000119517 | |
| Drug | L-368,899 | 3.11e-04 | 11 | 55 | 2 | CID000132857 | |
| Drug | Cyclic AMP | 3.23e-04 | 247 | 55 | 5 | ctd:D000242 | |
| Drug | isonicotinic acid | 3.72e-04 | 12 | 55 | 2 | CID000005922 | |
| Drug | CK 6 | 3.75e-04 | 58 | 55 | 3 | CID000447960 | |
| Drug | alkannin | 3.75e-04 | 58 | 55 | 3 | CID000005208 | |
| Drug | benzodiazepine | 3.86e-04 | 142 | 55 | 4 | CID000134664 | |
| Drug | Vasotocin | 3.94e-04 | 59 | 55 | 3 | CID000024774 | |
| Drug | 1 sulfonylurea | 3.97e-04 | 143 | 55 | 4 | CID011819083 | |
| Drug | AC1L1H8O | 4.14e-04 | 60 | 55 | 3 | CID000005106 | |
| Drug | IAA-94 | 4.35e-04 | 61 | 55 | 3 | CID000003667 | |
| Drug | pyrrole-2,3,5-tricarboxylic acid | 4.39e-04 | 13 | 55 | 2 | CID000150868 | |
| Drug | amido black | 4.39e-04 | 13 | 55 | 2 | CID005473482 | |
| Drug | Edotreotide | 4.39e-04 | 13 | 55 | 2 | CID000158782 | |
| Drug | IM-E | 4.56e-04 | 62 | 55 | 3 | CID005288624 | |
| Drug | wortmannin | 4.60e-04 | 267 | 55 | 5 | ctd:C009687 | |
| Disease | autoimmune thyroiditis (biomarker_via_orthology) | 2.31e-08 | 4 | 54 | 3 | DOID:7188 (biomarker_via_orthology) | |
| Disease | Keratoderma, Palmoplantar | 3.19e-06 | 16 | 54 | 3 | C4551675 | |
| Disease | autosomal recessive nonsyndromic deafness 1A (implicated_via_orthology) | 3.29e-06 | 2 | 54 | 2 | DOID:0110475 (implicated_via_orthology) | |
| Disease | Keratitis-Ichthyosis-Deafness Syndrome | 3.29e-06 | 2 | 54 | 2 | C3665333 | |
| Disease | DFNA 3 Nonsyndromic Hearing Loss and Deafness | 3.29e-06 | 2 | 54 | 2 | cv:CN043589 | |
| Disease | Senter syndrome | 3.29e-06 | 2 | 54 | 2 | C0265336 | |
| Disease | autosomal recessive nonsyndromic deafness 1A (is_implicated_in) | 3.29e-06 | 2 | 54 | 2 | DOID:0110475 (is_implicated_in) | |
| Disease | Malignant neoplasm of skin | 4.23e-06 | 59 | 54 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 4.23e-06 | 59 | 54 | 4 | C0037286 | |
| Disease | Deafness, autosomal dominant nonsyndromic sensorineural 3 | 9.85e-06 | 3 | 54 | 2 | cv: | |
| Disease | Progressive hearing loss stapes fixation | 9.85e-06 | 3 | 54 | 2 | C1844678 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A | 9.85e-06 | 3 | 54 | 2 | 220290 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB6 (disorder) | 9.85e-06 | 3 | 54 | 2 | C2673760 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB3 (disorder) | 9.85e-06 | 3 | 54 | 2 | C2673761 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder) | 9.85e-06 | 3 | 54 | 2 | C2673759 | |
| Disease | X-linked mixed hearing loss with perilymphatic gusher | 9.85e-06 | 3 | 54 | 2 | cv:C1844678 | |
| Disease | DEAFNESS, X-LINKED 2 | 9.85e-06 | 3 | 54 | 2 | 304400 | |
| Disease | Autosomal recessive nonsyndromic hearing loss 1A | 9.85e-06 | 3 | 54 | 2 | cv:C2673759 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 3.07e-05 | 330 | 54 | 6 | EFO_0004529, EFO_0004612 | |
| Disease | urethral obstruction (biomarker_via_orthology) | 3.28e-05 | 5 | 54 | 2 | DOID:12577 (biomarker_via_orthology) | |
| Disease | Hidrotic Ectodermal Dysplasia | 3.28e-05 | 5 | 54 | 2 | C0162361 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 5.75e-05 | 225 | 54 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | Diaphragmatic Hernia | 5.88e-05 | 41 | 54 | 3 | C0019284 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.47e-04 | 10 | 54 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | cystic fibrosis (is_marker_for) | 2.03e-04 | 62 | 54 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Allergic Reaction | 2.13e-04 | 63 | 54 | 3 | C1527304 | |
| Disease | Hypersensitivity | 2.23e-04 | 64 | 54 | 3 | C0020517 | |
| Disease | Petit mal status | 2.55e-04 | 67 | 54 | 3 | C0270823 | |
| Disease | Grand Mal Status Epilepticus | 2.55e-04 | 67 | 54 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.55e-04 | 67 | 54 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.55e-04 | 67 | 54 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.55e-04 | 67 | 54 | 3 | C0751523 | |
| Disease | Complex Partial Status Epilepticus | 2.55e-04 | 67 | 54 | 3 | C0393734 | |
| Disease | Status Epilepticus | 2.67e-04 | 68 | 54 | 3 | C0038220 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.77e-04 | 315 | 54 | 5 | EFO_0004574, EFO_0004612 | |
| Disease | gastric ulcer (implicated_via_orthology) | 2.95e-04 | 14 | 54 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 2.95e-04 | 14 | 54 | 2 | DOID:841 (is_marker_for) | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 4.39e-04 | 17 | 54 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | ischemia (biomarker_via_orthology) | 4.94e-04 | 18 | 54 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | borna disease (biomarker_via_orthology) | 4.94e-04 | 18 | 54 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | Usual Interstitial Pneumonia | 5.51e-04 | 19 | 54 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 5.51e-04 | 19 | 54 | 2 | C4721508 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 6.12e-04 | 20 | 54 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 6.75e-04 | 21 | 54 | 2 | C1800706 | |
| Disease | hearing impairment | 7.79e-04 | 98 | 54 | 3 | C1384666 | |
| Disease | Sensorineural Hearing Loss (disorder) | 8.11e-04 | 23 | 54 | 2 | C0018784 | |
| Disease | Behcet Syndrome | 8.84e-04 | 24 | 54 | 2 | C0004943 | |
| Disease | Oral ulcer | 1.01e-03 | 107 | 54 | 3 | HP_0000155 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.03e-03 | 243 | 54 | 4 | EFO_0004612, EFO_0020944 | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 1.04e-03 | 26 | 54 | 2 | EFO_0004612, MONDO_0004975 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.26e-03 | 257 | 54 | 4 | DOID:10652 (is_marker_for) | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.29e-03 | 29 | 54 | 2 | cv:C5779548 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.39e-03 | 264 | 54 | 4 | EFO_0008317, EFO_0020944 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.43e-03 | 121 | 54 | 3 | EFO_0004612, EFO_0005271 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus | 1.48e-03 | 31 | 54 | 2 | EFO_0000280, EFO_0000478 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRAMRLVVVVVVAFA | 251 | P49682 | |
| IIVMEHVVFLVKFLL | 836 | Q75V66 | |
| FVATVPVIVAFIMLR | 1016 | P13569 | |
| AFVKRVIMSRFFKII | 41 | Q86XQ3 | |
| FIIFCVLIAIMVKVN | 696 | Q99965 | |
| REKRFTFVLAVVMGV | 376 | P18825 | |
| VKMSFGLLRVFSIVI | 61 | Q9H4I9 | |
| VASVMPVVAFRFLKV | 1076 | Q8TF62 | |
| TVLFIFRIMILVVAA | 26 | P29033 | |
| AVAVILLVFQVFIIM | 191 | Q7Z602 | |
| GRRQVTKMLFVLVVV | 291 | Q9HB89 | |
| IKRAITFIMVVAIVF | 226 | Q8TDS4 | |
| IVTLKNGRVVMLVIF | 451 | O75882 | |
| MQKIIFVVFFVIYII | 21 | A6NHA9 | |
| AKMFVARVIVVAVPA | 196 | Q8NGV0 | |
| LVVFVAIVRKIISDM | 416 | Q2PZI1 | |
| FVIVVAVSVIMVIYL | 116 | Q9UIQ6 | |
| IVVMRSLFIDRTIVK | 201 | Q6P2C8 | |
| IRTVKMTFIIVLAFI | 271 | P30559 | |
| RIMVIINKVLRFTVT | 141 | Q5TGP6 | |
| FRVVAMLFIFLVVVE | 6 | Q02413 | |
| KMVLVLVVVFILSAA | 251 | Q969V1 | |
| FTIDFVEMKVKIIRT | 2661 | P04114 | |
| VFVVLMEIIAKVFLA | 2156 | Q13535 | |
| VAAKILAIISIMFIV | 186 | Q14721 | |
| IFTAVFLAEMTVKVV | 1316 | O43497 | |
| KAIRLIFVIMAVFFI | 236 | P51677 | |
| KAVRLIFVIMIIFFL | 236 | P32246 | |
| TVIFIFRVMILVVAA | 26 | O95452 | |
| ILKIVITIFTFGMKI | 506 | P51795 | |
| KTIFIIFMLVVSLVS | 206 | P17302 | |
| DVVIAIFIIVAMSFV | 1791 | Q9BZC7 | |
| SVIFIFRIMVLVVAA | 26 | P08034 | |
| TVIIVFAMIKIGQLF | 536 | P40197 | |
| KKATRFIMVVAIVFI | 216 | Q9BXC0 | |
| RPTEKTIFIIFMLAV | 196 | Q9Y6H8 | |
| RIFVMEAITFSVKVV | 116 | Q75VX8 | |
| VILAIFMVITALVKV | 141 | Q9BZD2 | |
| IKRAITFIMVVAIVF | 226 | P49019 | |
| KALRMILAVVLVFFV | 256 | Q99527 | |
| ILIVIFMITKFVQDR | 196 | O43567 | |
| KITRLVLMVVVVFVL | 256 | P31391 | |
| LMVVGRVFVVFLVVI | 426 | Q2M3M2 | |
| RIVVVLDSMIKVFTF | 111 | Q5MNZ6 | |
| MNIVVEFFVVTFKVL | 1 | Q8IZV5 | |
| EKKVTRMVSIVVAVF | 251 | P30874 | |
| MVKIFLILIVFFIIF | 336 | Q13190 | |
| TLVFTVMVFTVTLKL | 1006 | P98196 | |
| TMVVIFVIAVFTVAL | 171 | Q8TCT8 | |
| MARIPKTLKFVVVIV | 1 | O14798 | |
| KAIVINGILMTVVFF | 171 | Q96MV1 | |
| IMIFEKSVVFIVLLI | 161 | Q86TL2 | |
| RLVENVIMVLVFKFF | 356 | Q6PP77 | |
| VAKTVRMTLVIVVVY | 266 | P30518 | |
| VVFTFIFVLEVTMKI | 1246 | Q8IZF0 |